Viale-a
Phase 3 Unknown
154 enrolled
Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML
Phase 3 Unknown
170 enrolled
A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML
Phase 3 Unknown
500 enrolled
"InDACtion" vs "3+7" Induction in AML
Phase 3 Unknown
606 enrolled
Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
Phase 3 Unknown
30 enrolled
VAH Versus VA for Salvage Therapy of R/R-AML
Phase 3 Unknown
162 enrolled
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial
Phase 3 Unknown
130 enrolled
Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML
Phase 3 Unknown
60 enrolled
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine,Cytarabine, G-CSF for Refractory or Relapsed AML
Phase 3 Unknown
30 enrolled
ALIVE
Phase 3 Unknown
315 enrolled
PALG-AML1/2016
Phase 3 Unknown
582 enrolled
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase 3 Unknown
717 enrolled 14 charts
CALVI
Phase 3 Unknown
140 enrolled
Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias
Phase 3 Unknown
25 enrolled
Haplo-SCT vs ASCT With or Without Decitabine in AML CR1
Phase 3 Unknown
212 enrolled
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
Phase 3 Unknown
162 enrolled
Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60
Phase 3 Unknown
50 enrolled
A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC
Phase 3 Unknown
100 enrolled
MacHaploMud
Phase 3 Unknown
344 enrolled
Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy
Phase 3 Unknown
116 enrolled
Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia
Phase 3 Unknown
30 enrolled
IMCG-EAML
Phase 3 Unknown
196 enrolled
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Phase 3 Unknown
80 enrolled
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
Phase 3 Unknown
244 enrolled
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Phase 3 Unknown
2,000 enrolled
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
Phase 3 Unknown
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Phase 3 Unknown
IDBUCY
Phase 3 Unknown
200 enrolled
Ara-c
Phase 3 Unknown
180 enrolled
Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients
Phase 3 Unknown
46 enrolled
OSHO#061
Phase 3 Unknown
850 enrolled
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
Phase 3 Unknown
214 enrolled
AIvsAD
Phase 3 Unknown
316 enrolled
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
Phase 3 Unknown
1,520 enrolled
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
Phase 3 Unknown
2,000 enrolled
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
Phase 3 Unknown
207 enrolled
Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia
Phase 3 Unknown
100 enrolled